Abstract
Purpose To assess metamorphopsia in patients with macular telangiectasia (MacTel) type 2. Methods In a prospective observational cohort study, 40 eyes of 20 patients with MacTel type 2 were investigated by funduscopy, fluorescein angiography, optical coherence tomography and microperimetry. Metamorphopsia was assessed using Amsler grids following a standard protocol and standardized questionnaire. Results Metamorphopsia was present in 30 (83%) out of 36 nonproliferative eyes and in all four eyes with neovascular membranes. In the 30 nonproliferative eyes with distortions, metamorphopsia was always present in the nasal quadrant of the central visual field. Distortions were most pronounced in the nasal and lower quadrant in 70 and 30%, respectively. Three nonproliferative eyes with a very early and three eyes with a late disease stage did not perceive metamorphopsia. The degree of distortions was often but not necessarily correlated with the degree of leakage. Metamorphopsia was present in five out of eight eyes with normal sensitivity in microperimetry testing. Detection of scotoma by Amsler grid testing was poor. Conclusion Metamorphopsia is a frequent clinical symptom in MacTel type 2 even in the absence of neovascularization. Since macular thickness was within normal limits in such eyes, extensive swelling or distortion of the neurosensory retina would not account for metamorphopsia in contrast to other macular diseases such as age-related macular degeneration or idiopathic epiretinal membranes.
Similar content being viewed by others
References
Gass JD, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 100(10):1536–1546
Charbel Issa P, Scholl HPN, Helb HM, Holz FG (2007) Idiopathic macular telangiectasia. In: Holz FG, Spaide RF (eds) Medical retina. Springer, Berlin, pp 183–197
Charbel Issa P, Scholl HP, Gaudric A, Massin P, Kreiger AE, Schwartz S, Holz FG (2008) Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye 23:435–441
Charbel Issa P, Helb HM, Rohrschneider K, Holz FG, Scholl HPN (2007) Microperimetric assessment of patients with type II macular telangiectasia. Invest Ophthalmol Vis Sci 48(8):3788–3795
Charbel Issa P, Helb HM, Holz FG, Scholl HPN (2008) On behalf of the MacTel study group: correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol 245:169–175
Schmitz-Valckenberg S, Fan K, Nugent A, Rubin GS, Peto T, Tufail A, Egan C, Bird AC, Fitzke FW (2008) Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia. Arch Ophthalmol 126(3):330–335
Finger RP, Charbel Issa P, Fimmers R, Holz FG, Rubin GS, Scholl HPN (2009) Reading performance is reduced due to parafoveal scotomas in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci 50(3):1366–1370
Abujamra S, Bonanomi MT, Cresta FB, Machado CG, Pimentel SL (2000) Caramelli CB: idiopathic juxtafoveolar retinal telangiectasis: clinical pattern in 19 cases. Ophthalmologica 214(6):406–411
Gass JD (1982) Oyakawa RT: idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 100(5):769–780
Amsler M (1947) L’examen qualitatif de la fonction maculaire. Ophthalmologica 114:248–261
Amsler M (1953) Earliest symptoms of diseases of the macula. Br J Ophthalmol 37(9):521–537
Fujii GY, de Juan E Jr, Sunness J, Humayun MS, Pieramici DJ, Chang TS (2002) Patient selection for macular translocation surgery using the scanning laser ophthalmoscope. Ophthalmology 109(9):1737–1744
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174
Gaudric A, Ducos de LG, Cohen SY, Massin P, Haouchine B (2006) Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 124(10):1410–1419
Gass JDM (1997) Retinal capillary diseases. In: Stereoscopic atlas of macular diseases, vol 1, 4th edn. Mosby, St. Louis, pp 476–515
Paunescu LA, Ko TH, Duker JS, Chan A, Drexler W, Schuman JS, Fujimoto JG (2006) Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology 113(1):48–57
Achard OA, Safran AB, Duret FC, Ragama E (1995) Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol 120(3):322–329
Schuchard RA (1993) Validity and interpretation of Amsler grid reports. Arch Ophthalmol 111(6):776–780
Ramachandran VS, Gregory RL (1991) Perceptual filling in of artificially induced scotomas in human vision. Nature 350(6320):699–702
Gerrits HJ, Timmerman GJ (1969) The filling-in process in patients with retinal scotomata. Vision Res 9(3):439–442
Hazel CA, Petre KL, Armstrong RA, Benson MT, Frost NA (2000) Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci 41(6):1309–1315
Acknowledgments
Funding/Support BONFOR Program, grant O-137.0011 (Faculty of Medicine, University of Bonn); Marie Curie Intra European Fellowship (237238) within the 7th European Community Framework Programme; The Lowy Medical Research Institute; The Macular Telangiectasia Project; EU FP6, Integrated Project “EVI-GENORET” (LSHG-CT-2005-512036). Financial Disclosure No conflicting relationship exists for any author.
Conflict of interest
None of the authors has a financial relationship with the organization that sponsored the research. The funding organizations had no role in the design or conduct of this research. The authors had full control of all primary data and agree to allow the journal to review their data if requested. The contents of this publication reflect only the author’s views and not the views of the funding organizations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Charbel Issa, P., Holz, F.G. & Scholl, H.P.N. Metamorphopsia in patients with macular telangiectasia type 2. Doc Ophthalmol 119, 133–140 (2009). https://doi.org/10.1007/s10633-009-9190-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-009-9190-9